AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 119 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $147,000 | -67.0% | 15,608 | -57.4% | 0.00% | -100.0% |
Q4 2019 | $446,000 | +284.5% | 36,654 | +266.5% | 0.00% | – |
Q3 2019 | $116,000 | +2.7% | 10,000 | -11.4% | 0.00% | – |
Q2 2019 | $113,000 | -83.2% | 11,284 | -74.6% | 0.00% | -100.0% |
Q4 2018 | $673,000 | +69.5% | 44,345 | +125.1% | 0.00% | 0.0% |
Q1 2018 | $397,000 | +146.6% | 19,700 | +62.6% | 0.00% | – |
Q4 2017 | $161,000 | -22.6% | 12,115 | +7.5% | 0.00% | -100.0% |
Q3 2017 | $208,000 | -48.4% | 11,273 | -36.8% | 0.00% | -50.0% |
Q1 2017 | $403,000 | +52.7% | 17,851 | +65.7% | 0.00% | +100.0% |
Q3 2016 | $264,000 | -7.7% | 10,776 | -9.9% | 0.00% | 0.0% |
Q2 2016 | $286,000 | -5.0% | 11,955 | -7.1% | 0.00% | -50.0% |
Q1 2016 | $301,000 | -76.8% | 12,874 | -31.6% | 0.00% | -75.0% |
Q2 2015 | $1,300,000 | +101.2% | 18,826 | +59.1% | 0.01% | +60.0% |
Q1 2015 | $646,000 | -60.2% | 11,834 | -76.8% | 0.01% | -70.6% |
Q3 2014 | $1,624,000 | – | 50,902 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |